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Abstract
Introduction: Familial interstitial lung disease has been reported worldwide, mostly in Europe and
North America; limited information is available on the disease among Arab patients.
Case presentation: A 45-year-old woman presented to our outpatient clinic with a 1-year
history of progressive dyspnea. At the age of 37 years, based on clinical and radiological features,
our patient was diagnosed with idiopathic pulmonary fibrosis. A family history showed that of five
deceased siblings, four had died of disease of undetermined etiology. In addition, we screened other
family members, and three were shown to have clinical, radiological, and pathological features
consistent with interstitial pneumonia.
Conclusion: Our report illustrates that younger age at presentation appears to be a common
feature in patients with familial interstitial pneumonia. Otherwise, clinical, radiological, and
histological features are indistinguishable from those of sporadic cases. Furthermore, our work
highlights the importance of compiling a thorough family history in individuals presenting with
cough and dyspnea, particularly in younger patients identified with idiopathic pulmonary fibrosis.
Introduction
Familial idiopathic interstitial pneumonia is defined as
when two or more members of the same family have clin-
ical features of interstitial pneumonia [1,2]. To date,
approximately 150 such families have been reported
worldwide. Characteristically, patients with familial idio-
pathic pulmonary fibrosis (IPF) present at a younger age
and screening of family members shows evidence of early
interstitial changes in asymptomatic subjects [1,3,4].
Thus, examination of family members with idiopathic
interstitial pneumonia provides an opportunity to
uncover the pathogenesis of IPF at early stages when ther-
apy might be effective. We describe four siblings with
interstitial lung disease, three of whom were identified
after taking a thorough family history from a patient, fol-
lowed by family screening.
Case presentation
Case report 1
A 45-year-old female Saudi Arabia, non-smoker presented
to our outpatient clinic in January 2009 for a second opin-
ion; she had a 1-year history of progressive dyspnea of
New York Heart Association class III. The patient had been
diagnosed with idiopathic pulmonary fibrosis (IPF) at the
age of 37 years, based on a high-resolution computed
tomography (HRCT) scan, and since that time she had
taken corticosteroids, was home oxygen-dependent, and
had been referred for lung transplantation abroad. Her
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sputum production in the morning. She had worked as a
schoolteacher for 15 years. A family history revealed that
five siblings had died, one at the age of 13 years from con-
genital heart disease, and four from conditions of unde-
termined etiology, when all were less than 1 year old. In
addition several members of her first and second genera-
tions had died from respiratory failure possibly related to
underlying interstitial lung disease (Figure 1). Other fam-
ily members revealed cough and dyspnea in cases 2 and 3,
and cough with sputum production in case 4.
On examination our patient had digital clubbing and
bibasilar end-inspiratory crackles on auscultation. Pulmo-
nary function and 6-minute walk test (6MWT) results are
shown in Table 1. Pulmonary function studies and
6MWD data), which revealed a severe restrictive defect,
with marked oxygen desaturation to 83% after the 6-
minute walk even with 2 L of oxygen supplementation.
Her Borg score was 6 at the end of the walk test indicating
moderately severe dyspnea. A blood test was positive for
antinuclear antibody (ANA) 1:640 of the speckled pat-
tern, but other serological studies for collagen vascular
disease were negative. A HRCT scan demonstrated ground
glass attenuation, reticular opacities, traction bronchiecta-
sis, and bronchiolectasis with honeycombing throughout
both lungs (Figure 2). The patient was instructed to pro-
ceed with lung transplantation evaluation.
Case report 2
The 48-year-old female from Saudi Arabia, elder sister of
case 1 complained of dyspnea on exertion, and cough
with sputum production in the morning, for 3 years. She
had been diagnosed with bronchial asthma at the age of
46 years. She had never smoked. She works as a school-
teacher. A physical review was unremarkable. On exami-
nation, she was not clubbed or cyanosed. Bibasilar end-
inspiratory crackles were noted on auscultation. Pulmo-
nary function test data as shown in Table 1. Pulmonary
function studies and 6MWD data) indicated a restrictive
defect with a markedly reduced diffusion capacity for car-
bon monoxide (DLCO). A blood test was positive for
ANA 1:160, with a homogenous pattern. Other serologi-
cal studies for collagen vascular disease were negative. A
HRCT scan revealed inhomogeneous ground glass attenu-
ation with reticular and nodular densities, associated with
irregular pleural thickening with a shaggy pleuropulmo-
nary interface, traction bronchiectasis, and fine honey-
combing. HRCT scan obtained at the upper lung zones
shows reticular opacities and honeycombing (Figure 3a).
HRCT scan from the basal parts of the lungs showing
ground-glass attenuation, reticular and nodular densities,
and traction bronchiectasis (Figure 3b).
A video-assisted thoracoscopic surgical lung biopsy was
performed from the lingula, and the lateral basal segment
of the left lower lobe showed an unclassifiable form of
interstitial fibrosis (Figure 4). Thoracoscopic lung biopsy
showing areas of interstitial fibrosis alternating with less
involved parenchyma. (haematoxylin and eosin stain) at
×10 magnification). Our patient has clinically improved
after commencement on prednisone, azathioprine, and
N-acetylcysteine.
Pedigree of three generations of a family with familial idiopathic interstitial pneumoniaFigu  1
Pedigree of three generations of a family with familial idiopathic interstitial pneumonia.Page 2 of 8
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The third sister, 43 years of age from Saudi Arabia,
reported dyspnea upon heavy exertion, an occasional dry
cough, and chest discomfort for the past 1 year. Her med-
ical history included diabetes mellitus and hypothy-
roidism, 6 years in duration. She had never smoked but
had been exposed to secondhand smoke. She works as a
schoolteacher. Physical examination did not reveal any
abnormal finding. The results of physiologic testing are
shown in Table 1. Pulmonary function studies and
6MWD data) and indicate a restrictive defect with a mark-
edly reduced DLCO, but no significant oxygen desatura-
tion after the 6MWT. Serological studies for collagen
vascular disease were negative. HRCT revealed fine reticu-
lar infiltrates associated with focal ground glass attenua-
tion in the upper zones, mild bronchial wall thickening,
and multilobular areas of air trapping predominantly in
the lower zones. HRCT scan obtained from the upper lung
zones shows interlobular reticular opacities and patchy
ground-glass attenuation (Figure 5a). HRCT scan at the
basal portion of the lungs showing multilobular regions
of air trapping (Figure 5b). A thoracoscopic lung biopsy
demonstrated features consistent with hypersensitivity
pneumonia. Thoracoscopic lung biopsy showing chronic
interstitial inflammation with prominent bronchiolocen-
tricity (haematoxylin and eosin stain) at ×10 magnifica-
tion (Figure 6a). Higher magnification showing poorly
formed granuloma. (haematoxylin and eosin stain) at ×40
magnification) (Figure 6b). The patient was urged to
avoid passive smoking, and reported improvement in
symptoms after commencing on prednisone and N-ace-
tylcysteine.
Case 4
The younger brother, aged 30 years from Saudi Arabia,
complained of sputum production and cough for the last
2 years. He had been diagnosed with bronchial asthma at
the age of 28 years. He worked as a customer service rep-
resentative, with frequent exposure to diesel exhaust. He
had smoked 20-30 cigarettes daily for 10 years. On exam-
ination, he was not clubbed or cyanosed, and his chest
was clear on auscultation. The pulmonary function test
demonstrated a mild obstructive and restrictive defect
with no significant impairment in DLCO and a normal
6MWT Table 1. Pulmonary function studies and 6MWD
data). HRCT showed diffuse bronchial wall thickening
and poorly defined centrilobular nodules (Figure 7).
HRCT scan obtained at the upper lung zones showing
poorly defined centrilobular nodules with diffuse bron-
chial wall thickening throughout both lung fields). A sur-
gical lung biopsy demonstrated pigmented macrophages
in and around the small bronchioles (Figure 8). Thoraco-
scopic lung biopsy showing pigmented macrophages in
and around small bronchioles, interstitial thickening and
peribronchiolar inflammatory changes (haematoxylin
Case 1Figure 2
Case 1. High-resolution computed tomography (HRCT) 
scan at the basal portion of the lungs demonstrating ground-
glass attenuation, reticular opacities, traction bronchiectasis, 
with honeycombing throughout both lungs.
Table 1: Pulmonary function studies and 6MWD data.
Variables Case 1 Case 2 Case 3 Case 4
FVC, % predicted 27.6 84.9 61.9 78
FEV1, % predicted 31 86.7 78.1 75
TLC, % predicted 31.9 70.6 43.7 87.6
DLCO, % predicted - 30.2 32.9 82.4
PaO2, mmHg 68 68 87 -
PaCO2, mmHg 53 29 41 -
SaO2 at rest, % 93 94 97 -
Distance, m 122 372 362 506
Initial SPO2, % 93 97 95 96
Lowest SPO2, % 83 96 93 98
Initial Borg Score 0 0 0 0
Final Borg Score 6 1 3 1Page 3 of 8
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in line with clinical and radiological findings, was consist-
ent with the diagnosis of respiratory bronchiolitis-associ-
ated interstitial lung disease (RB-ILD). The patient quit
smoking after counseling.
Discussion
Idiopathic interstitial pneumonias are a group of diffuse
infiltrative lung diseases of unknown etiology composed
of several clinicopathologic subtypes including IPF also
known as usual interstitial pneumonia (UIP), which is the
most common subtype; nonspecific interstitial pneumo-
nia (NSIP); respiratory bronchiolitis-associated interstitial
lung disease (RB-ILD); desquamative interstitial pneumo-
nia (DIP); cryptogenic organizing pneumonia (COP);
acute interstitial pneumonia (AIP); and lymphocytic
interstitial pneumonia (LIP) [5]. Familial IPF is defined as
when two or more members of the same family show clin-
ical features of idiopathic interstitial pneumonia [1,2].
The condition was first described in 1907 by Sandoz [6].
Another report [7] described IPF in identical twin sisters
and since that time 15 definite cases and 3 other probable
cases of pulmonary fibrosis have been diagnosed in the
same family [8]. The exact prevalence of familial IPF is
unknown, however two recent studies suggest that 0.5-
3.7% of all patients with IPF have disease of the familial
type [9,10]. The mode of inheritance of familial IPF is not
entirely clear; however, the observed father-to-son trans-
mission excludes X-chromosome linkage, whereas a sin-
gle report suggested that inheritance is an autosomal
recessive trait [11]. The majority of reported cases demon-
strate an autosomal dominant characteristic with reduced
penetrance [1,2,8,10,12]. Sporadic IPF usually presents
between 50 and 70 years of age. Progressive dyspnea upon
exertion, nonproductive cough, clubbing of the digits,
and bibasilar end-inspiratory crackles constitute the typi-
cal clinical presentation. In a retrospective study, Lee and
colleagues examined 27 patients from 15 families with
familial IPF [2]. The clinical findings, pulmonary function
testing, pathologic changes, radiographic features, and
survival data were similar in patients with familial IPF and
Case 2Figure 3
Case 2. (a) HRCT scan obtained at the upper lung zones shows reticular opacities and honeycombing. (b) HRCT scan from 
the basal parts of the lungs showing ground-glass attenuation, reticular and nodular densities, and traction bronchiectasis.
Case 2Figure 4
Case 2. Thoracoscopic lung biopsy showing areas of intersti-
tial fibrosis alternating with less involved parenchyma. (hae-
matoxylin and eosin stain) at ×10 magnificationPage 4 of 8
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patients and bilateral irregular linear opacities were seen
in all cases. Other findings included a subpleural predom-
inance of linear opacities (94%), subpleural traction
bronchiectasis (82%), emphysematous changes (18%),
ground glass opacities (12%), and bronchial wall thicken-
ing with irregularities (6%). Although the cited investiga-
tors concluded that the radiographic features of familial
IPF and non-familial IPF were similar, a lower incidence
of honeycombing (29%) was seen in familial IPF patients
compared to those with non-familial IPF. Nishiyama and
colleagues [13] described HRCT findings in nine patients
with biopsy-proven familial IPF, and found a resemblance
between familial IPF and non-familial IPF, except that the
prevalence of honeycombing (33%) and lower lung zone
distribution (67%) was lower in familial IPF patients
compared to those with non-familial IPF. Nevertheless, a
follow-up HRCT study revealed disease progression and
Case 3Figure 5
Case 3. (a) HRCT scan obtained from the upper lung zones shows interlobular reticular opacities and patchy ground-glass 
attenuation. (b) HRCT scan at the basal portion of the lungs showing multilobular regions of air trapping.
Case 3Figure 6
Case 3. (a) Thoracoscopic lung biopsy showing chronic interstitial inflammation with prominent bronchiolocentricity. (haema-
toxylin and eosin stain) at ×10 magnification. (b) Higher magnification showing poorly formed granuloma. (haematoxylin and 
eosin stain) at ×40 magnificationPage 5 of 8
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familial IPF [2,13]. Age at onset appears to be lower in
patients with familial IPF, who usually present with symp-
toms during the third or fourth decade of life [14]. This
probably results from early screening of non-affected fam-
ily members as demonstrated in our present case report.
Interestingly, 50% of asymptomatic first-degree relatives
of subjects affected by familial IPF have a pattern of alve-
olar inflammation similar to that observed in patients
with sporadic IPF in the absence of detectable abnormali-
ties in pulmonary function or chest radiography [4]. In
another study, Steel and associates reported on the clinical
features of familial idiopathic interstitial pneumonia, and
found that almost 8% of subjects without symptoms of
pulmonary fibrosis had HRCT findings consistent with
probable or definite interstitial pneumonia [1]. Rosas and
colleagues evaluated family members of patients affected
by familial IPF to identify asymptomatic subjects with
interstitial lung disease (ILD) [3]. The cited authors found
that 22% of asymptomatic subjects showed radiographic
evidence of ILD when screened by HRCT. A consistent
finding in previous studies was that a history of cigarette
smoking was strongly associated with the development of
early ILD in family members of those with familial inter-
stitial pneumonia [1,3]. This suggests that a genetically
susceptible individual may develop lung injury from ciga-
rette smoking and exposure to other environmental toxins
that may stimulate fibroproliferation, further increasing
the risk of developing ILD and progression of pulmonary
fibrosis. Several studies have revealed heterogeneity of
histopathologic findings in family members of individu-
als with familial IPF [1,3,15]. In one study, approximately
45% of family members showed more than one histologic
subtype when relatives of those affected by familial inter-
stitial pneumonia were surveyed [1]. The reported combi-
nations of histologic types within families include: UIP
and NSIP; UIP, NSIP, and COP; UIP, NSIP, and RB-ILD;
UIP and unclassified ILD; or UIP and hypersensitivity
pneumonia [1,3,15]. Although the clinical and morpho-
logic features of various histologic types of idiopathic
interstitial pneumonia differ from those of UIP, the con-
ditions may perhaps represent gradations of a spectrum of
which UIP is the final histopathologic result. Such specu-
lation is supported by the simultaneous occurrence of UIP
and NSIP in the same patient with idiopathic interstitial
pneumonia [16], as well the similarity in gene expression
profile between UIP and NSIP [17] patients. In the present
case report, an examination of the pedigree of three gen-
erations revealed several deaths that occurred both during
infancy and adult life. It is possible to speculate that
affected individuals might share a single candidate genetic
alteration such as a mutation in the surfactant protein C
(SP-C) gene (SFTPC), resulting in development of pulmo-
nary fibrosis in our studied family. However, other inves-
tigators believe that early onset cases of ILD are distinct,
arising from a pathogenic mechanism different from that
causing adult onset occurrence of familial IPF [10]. Four
surfactant proteins (SPs) have been identified and are
divided into two groups: the hydrophilic proteins SP-A
and SP-D and the hydrophobic proteins SP-B and SP-C.
SP-A, SP-B, and SP-D are synthesized by both alveolar
cells and nonciliated bronchiolar cells of the lung,
Case 4Figure 7
Case 4. HRCT scan obtained at the upper lung zones show-
ing poorly defined centrilobular nodules with diffuse bron-
chial wall thickening throughout both lung fields.
Case 4Figure 8
Case 4. Thoracoscopic lung biopsy showing pigmented mac-
rophages in and around small bronchioles. (haematoxylin and 
eosin stain) at ×10 magnificationPage 6 of 8
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C plays a critical role in reducing surface tension in the
alveoli, whereas SP-C absence or mutation in SFTPC
mutant patients causes mechanical injury to the respira-
tory epithelium leading to respiratory failure and severe
ILD [18]. This was first reported by Nogee and colleagues
who described a mother with desquamative interstitial
pneumonia, and her infant with NSIP [19]. In another
study, Thomas and co-workers reported a heterozygous T
to A substitution in the fifth exon of the SFTPC gene that
was associated with adult onset UIP with childhood cellu-
lar NSIP [15]. Recently, Selman and colleagues evaluated
genetic polymorphic variants of the surfactant proteins
SP-A1, SP-A2, SP-B, SP-C, and SP-D in a group of patients
with IPF [20]. The SP-A1_6A4 allele was noted to be asso-
ciated with nonsmoker IPF, whereas the SP-B B1580_C
allele was more associated with smoker IPF patients com-
pared to control subjects. Thus, in line with previous stud-
ies, SPs appear to play an essential role in the
pathogenesis of both familial and sporadic IPF. Pulmo-
nary fibrosis has also been associated with other rare
genetic disorders yielding pleiotropic presentations,
including Hermansky-Pudlak syndrome, neurofibroma-
tosis, tuberous sclerosis, Niemann-Pick disease, Guacher
disease, familial hypocalciuric hypercalcemia, and con-
genital dyskeratosis. The management of patients with
familial IIP is similar to that applied to sporadic cases and
is dependent upon the type of IIP diagnosed, However, to
date, lung transplantation is the only therapy that has
been shown to improve survival in younger individuals
with pulmonary fibrosis.
Conclusion
Our report illustrates the importance of obtaining a
detailed family history, as such information can assist in
the diagnosis and early intervention in ILD patients. Clin-
ical findings, histopathology, and radiographic features
are indistinguishable between familial idiopathic intersti-
tial pneumonia and sporadic cases. Younger age at diag-
nosis is a common finding in patients with the former
condition. Cigarette smoking is strongly associated with
development of early ILD in family members with famil-
ial interstitial pneumonia, and both patients and asymp-
tomatic individuals should be urged to stop smoking.
Abbreviations
6MWD: six-minute walk distance in meters; FVC: forced
vital capacity; FEV1: forced vital capacity in 1 second;
PaO2: partial pressure of oxygen; PaCO2: partial pressure
of carbon dioxide; SaO2: oxygen saturation; SPO2: oxygen
saturation by pulse oximetry; TLC: total lung capacity.
Consent
Written informed consent was obtained from all patients
for publication of this case report and the accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of the Journal.
Competing interests
The author declares that they have no competing interests.
Acknowledgements
We thank Prof. Thomas Colby (Chair, Department of Laboratory Medicine 
& Pathology, Mayo Clinic, Scottsdale, Arizona, U.S.A.) for reviewing patient 
pathology. Dr Hala Kassouf, and Dr Hisham Al Khalidi kindly provided the 
digital pathological images. We thank the subject family for their participa-
tion in the study, and for providing personal information. The author appre-
ciates the technical support given by Dalia Othman.
References
1. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, Burch
LH, Wahidi MM, Phillips JA, Sporn TA, McAdams HP, Schwarz MI,
Schwartz DA: Clinical and pathologic features of familial inter-
stitial pneumonia.  Am J Respir Crit Care Med 2005,
172(9):1146-1152.
2. Lee HL, Ryu JH, Wittmer MH, Hartman TE, Lymp JF, Tazelaar HD,
Limper AH: Familial idiopathic pulmonary fibrosis: clinical fea-
tures and outcome.  Chest 2005, 127(6):2034-2041.
3. Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, Travis WD, McCoy
JP Jr, May RM, Wu HP, Nguyen DM, Arcos-Burgos M, MacDonald SD,
Gochuico BR: Early interstitial lung disease in familial pulmo-
nary fibrosis.  Am J Respir Crit Care Med 2007, 176(7):698-705.
4. Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crys-
tal RG: Familial idiopathic pulmonary fibrosis. Evidence of
lung inflammation in unaffected family members.  N Engl J
Med 1986, 314(21):1343-1347.
5. American Thoracic Society/European Respiratory Society: Interna-
tional Multidisciplinary Consensus Classification of the Idio-
pathic Interstitial Pneumonias. This joint statement of the
American Thoracic Society (ATS), and the European Respi-
ratory Society (ERS) was adopted by the ATS board of direc-
tors, June 2001 and by the ERS Executive Committee, June
2001.  Am J Respir Crit Care Med 2002, 165(2):277-304.
6. Sandoz E: Uber zwei Falle von fotaler Bronchektasie.  Beitr
Pathol Anat 1907, 41:495-516.
7. Peabody JW, Peabody JW Jr, Hayes EW, Hayes EW Jr: Idiopathic
pulmonary fibrosis; its occurrence in identical twin sisters.
Dis Chest 1950, 18(4):330-344.
8. Marney A, Lane KB, Phillips JA, Riley DJ, Loyd JE: Idiopathic pulmo-
nary fibrosis can be an autosomal dominant trait in some
families.  Chest 2001, 120(Suppl 1):56S.
9. Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of
sporadic and familial idiopathic pulmonary fibrosis: evidence
of founder effect among multiplex families in Finland.  Thorax
2002, 57(4):338-342.
10. Marshall RP, Puddicombe A, Cookson WO, Laurent GJ: Adult famil-
ial cryptogenic fibrosing alveolitis in the United Kingdom.
Thorax 2000, 55(2):143-146.
11. Tsukahara MKT: Interstitial pulmonary fibrosis in two sisters.
Possible autosomal recessive inheritance.  Jinrui Idengaku Zasshi
1983, 28(2):263-267.
12. Musk AW, Zilko PJ, Manners P, Kay PH, Kamboh MI: Genetic stud-
ies in familial fibrosing alveolitis. Possible linkage with immu-
noglobulin allotypes (Gm).  Chest 1986, 89(2):206-210.
13. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Katoh T, Oishi T,
Matsumoto S, Yokoi T, Takagi K, Shimokata K, Johkoh T, Muller NL:
Familial idiopathic pulmonary fibrosis: serial high-resolution
computed tomography findings in 9 patients.  J Comput Assist
Tomogr 2004, 28(4):443-448.
14. Barzo P: Familial idiopathic fibrosing alveolitis.  Eur J Respir Dis
1985, 66(5):350-352.
15. Thomas AQ, Lane K, Phillips J, Prince M, Markin C, Speer M, Schwartz
DA, Gaddipati R, Marney A, Johnson J, Roberts R, Haines J, Stahlman
M, Loyd JE: Heterozygosity for a surfactant protein C gene
mutation associated with usual interstitial pneumonitis and
cellular nonspecific interstitial pneumonitis in one kindred.
Am J Respir Crit Care Med 2002, 165(9):1322-1328.Page 7 of 8
(page number not for citation purposes)
Cases Journal 2009, 2:9356 http://www.casesjournal.com/content/2/1/9356Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
16. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross
BH, Jain A, Strawderman RL, Flint A, Lynch JP, Martinez FJ: His-
topathologic variability in usual and nonspecific interstitial
pneumonias.  Am J Respir Crit Care Med 2001, 164(9):1722-1727.
17. Yang IV, Burch LH, Steele MP, Savov JD, Hollingsworth JW, McElva-
nia-Tekippe E, Berman KG, Speer MC, Sporn TA, Brown KK, Schwarz
MI, Schwartz DA: Gene expression profiling of familial and spo-
radic interstitial pneumonia.  Am J Respir Crit Care Med 2007,
175(1):45-54.
18. Whitsett JA: Genetic basis of familial interstitial lung disease:
misfolding or function of surfactant protein C?  Am J Respir Crit
Care Med 2002, 165(9):1201-1202.
19. Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA: A
mutation in the surfactant protein C gene associated with
familial interstitial lung disease.  N Engl J Med 2001,
344(8):573-579.
20. Selman M, Lin HM, Montaño M, Jenkins AL, Estrada A, Lin Z, Wang
G, DiAngelo SL, Guo X, Umstead TM, Lang CM, Pardo A, Phelps DS,
Floros J: Surfactant protein A and B genetic variants predis-
pose to idiopathic pulmonary fibrosis.  Hum Genet 2003,
113(6):542-550.Page 8 of 8
(page number not for citation purposes)
